PharmaCyte Biotech, Inc. Common Stock Share Price
NASDAQ: PMCBHealthcare
Live PharmaCyte Biotech, Inc. Common Stock Share Price Chart
O H L
PharmaCyte Biotech, Inc. Common Stock Performance Overview
Days Range
▼
$0.41Low
$0.44High
Markets Today
| Previous Close | $0.42 |
|---|---|
| Open | $0.41 |
| Volume | 462,547 |
| Day's Range | $0.41 - $0.44 |
| 52W Range | $0.33 - $1.51 |
| Market Cap | $4.47 M |
Historical Performance
| 1M Returns | -19.10 |
|---|---|
| 3M Returns | -40.93 |
| 6M Returns | -39.43 |
| 1Y Returns | -56.32 |
| 5Y Returns | -88.22 |
| 10Y Returns | NA |
PharmaCyte Biotech, Inc. Common Stock Fundamentals
| Market Cap | $4.47 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -0.54 |
| EPS TTM | $-3.09 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 0.13 |
| EBITDA | $-5.30 M |
| Profit Margin | N/A |
| Market Cap | $4.47 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -0.54 |
| EPS TTM | $-3.09 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 0.13 |
| EBITDA | $-5.30 M |
| Profit Margin | N/A |
PharmaCyte Biotech, Inc. Common Stock Profit & Loss
Quarterly
| Apr 2025 | Jul 2025 | Oct 2025 | Jan 2026 | Apr 2026 | Jul 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit + | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$1.04 M | -$848.30 K | -$1.38 M | -$2.12 M | -$5.89 M | -$1.01 M |
| EBITDA | -$1.04 M | -$848.30 K | -$1.38 M | -$2.12 M | -$4.34 M | -$1.01 M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Depreciation | $0 | $0 | $0 | $0 | $1.55 M | $0 |
| Income Before Tax | $11.75 M | -$8.36 M | -$7.42 M | $746.86 K | -$16.38 M | -$5.08 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | $11.75 M | -$8.36 M | -$7.42 M | $746.86 K | -$16.38 M | -$5.08 M |
| Net Profit Margin | - | - | - | - | - | - |
PharmaCyte Biotech, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Apr 2025 | Jul 2025 | Oct 2025 | Jan 2026 | Apr 2026 | Jul 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $2.17 K | $2.17 K | $2.17 K | $2.60 K | $2.60 K | $2.60 K |
| Reserve & Surplus | -$84.99 M | -$93.35 M | -$100.77 M | -$100.02 M | -$104.41 M | -$109.50 M |
| Non-Current Liabilities | $363.00 K | $458.00 K | $17.84 M | $14.79 M | $10.95 M | $6.13 M |
| Current Liabilities | $2.91 M | $1.06 M | $1.58 M | $1.68 M | $826.42 K | $768.68 K |
| Total Liabilities | $3.28 M | $1.52 M | $19.42 M | $16.47 M | $11.77 M | $6.90 M |
| Fixed Assets | $1.55 M | $1.55 M | $1.55 M | $1.55 M | $0 | $0 |
| Current Assets | $22.38 M | $19.11 M | $23.02 M | $20.70 M | $37.42 M | $30.97 M |
| Total Assets | $55.17 M | $45.11 M | $55.98 M | $55.87 M | $46.75 M | $36.71 M |
PharmaCyte Biotech, Inc. Common Stock Cash Flow
Quarterly
| Apr 2025 | Jul 2025 | Oct 2025 | Jan 2026 | Apr 2026 | Jul 2026 | |
|---|---|---|---|---|---|---|
| Net Income | $11.75 M | -$8.36 M | -$7.42 M | $746.86 K | -$4.39 M | -$5.08 M |
| Operating Cash Flow | -$1.04 M | -$1.99 M | -$979.52 K | -$786.85 K | -$1.39 M | -$780.89 K |
| Investing Cash Flow | $0 | $0 | -$3.00 M | $5.00 M | $0 | $0 |
| Financing Cash Flow | -$171.54 K | $0 | $6.21 M | $543.78 K | -$169.82 K | -$83.40 K |
| Change in Cash | -$1.21 M | -$1.99 M | $2.23 M | $4.76 M | -$1.56 M | -$864.91 K |
PharmaCyte Biotech, Inc. Common Stock Return Calculator
The PharmaCyte Biotech, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$1,111
Invested Amount$10,000
Est. Returns$-8,889
About PharmaCyte Biotech, Inc. Common Stock
PharmaCyte Biotech Inc is a biotechnology company focused on developing cellular therapies for cancer based on its proprietary cellulose-based live cell encapsulation technology, Cell-in-a-Box. The technology is intended to be used as a platform for therapies for several types of cancer, including locally advanced, inoperable pancreatic cancer (LAPC). The current generation of the Company's product candidate is CypCaps. The Company is preparing to commercialize cellular therapies for cancer and advance clinical research and development, including a clinical trial in LAPC using encapsulated live cells. Its candidate therapy involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active, cancer-killing form.
Popular Stocks
FAQs
What is the share price of PharmaCyte Biotech, Inc. Common Stock today?
PharmaCyte Biotech, Inc. Common Stock (PMCB) share price as of September 18, 2026 is $0.40. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of PharmaCyte Biotech, Inc. Common Stock?
Yes, Indian Investors can invest in the PharmaCyte Biotech, Inc. Common Stock (PMCB) Share by opening an international trading account with Angel One.
How can I purchase PharmaCyte Biotech, Inc. Common Stock shares in India?
Purchasing PharmaCyte Biotech, Inc. Common Stock (PMCB) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying PharmaCyte Biotech, Inc. Common Stock (PMCB) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of PharmaCyte Biotech, Inc. Common Stock?
Yes, you can purchase fractional shares of PharmaCyte Biotech, Inc. Common Stock (PMCB) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of PharmaCyte Biotech, Inc. Common Stock?
The market capitalization of PharmaCyte Biotech, Inc. Common Stock on September 18, 2026, is $4.47 M.
In which sector PharmaCyte Biotech, Inc. Common Stock belongs?
PharmaCyte Biotech, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in PharmaCyte Biotech, Inc. Common Stock stocks?
In order to invest in PharmaCyte Biotech, Inc. Common Stock (PMCB) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
